City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.S ...

Drugs like Ozempic already have a big impact on how much patients eat - and now they may be changing the way they shop and ...

Changes in purchasing patterns after glucagon-like peptide-1 receptor agonist (GLP-1RA) initiation were seen across most nutrient ...

Key market opportunities for GLP-1 analogues include growth in the oral administration segment, expanding presence in Asia-Pacific and emerging markets, and strategic partnerships. Regulatory ...

Grocery industry organisation IGD (the Institute of Grocery Distribution) has launched an insight programme focused on GLP-1 ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in ...

Prayagraj: Associate professor in department of cardiology, MLN Medical College, Dr Abhishek Sachdeva, delivered a lecture on ...

Recent GLP-1 (glucagon-like peptide-1) obesity treatments such as ‘Wegovy’ and ‘Mounjaro’ have gained immense popularity, but ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...

Tia Timmer was always “on the heavier side,” but her weight never held her back – until she had to keep up with two grandchildren.